 | Up a level |
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Beliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M.-K., Juneau, D., DaSilva, J. N., Carrier, J.-F., Hautvast, G., & Menard, C. (2022). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and Oncology, 166, 154-161. External link
Menard, C., Navarro-Domenech, I., Liu, Z. (.A.)., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Beliveau-Nadeau, D., Helou, J., & Chun, P. (2022). Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 2 pages. External link
Menard, C., Navarro-Domenech, I., Liu, Z. (.A.)., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Beliveau-Nadeau, D., Helou, J., & Chun, P. (2022). MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 971344 (9 pages). External link
